TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,969,000 | -62.9% | 207,025 | -25.9% | 0.00% | -75.0% |
Q4 2021 | $5,311,000 | -41.8% | 279,206 | +1.8% | 0.00% | -42.9% |
Q3 2021 | $9,131,000 | +1.9% | 274,369 | +18.8% | 0.01% | -12.5% |
Q2 2021 | $8,960,000 | +36.2% | 230,975 | +69.3% | 0.01% | +33.3% |
Q1 2021 | $6,577,000 | +2.4% | 136,461 | +10.6% | 0.01% | 0.0% |
Q4 2020 | $6,420,000 | +59.0% | 123,421 | -18.2% | 0.01% | +20.0% |
Q3 2020 | $4,037,000 | +55.3% | 150,874 | +13.1% | 0.01% | +66.7% |
Q2 2020 | $2,600,000 | +145.1% | 133,457 | +23.8% | 0.00% | +200.0% |
Q1 2020 | $1,061,000 | -34.9% | 107,836 | -26.6% | 0.00% | 0.0% |
Q4 2019 | $1,630,000 | +71.6% | 146,891 | -13.4% | 0.00% | 0.0% |
Q3 2018 | $950,000 | -53.5% | 169,628 | +9.2% | 0.00% | -50.0% |
Q2 2018 | $2,042,000 | -7.9% | 155,312 | -0.6% | 0.00% | 0.0% |
Q1 2018 | $2,218,000 | +96.1% | 156,211 | +13.2% | 0.00% | +100.0% |
Q4 2017 | $1,131,000 | -26.2% | 137,980 | +6.6% | 0.00% | 0.0% |
Q3 2017 | $1,533,000 | +22.2% | 129,378 | +3.6% | 0.00% | 0.0% |
Q2 2017 | $1,255,000 | – | 124,848 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |